Conference Call and Webcast at 8:30AM Eastern Time
NEW
YORK, Oct. 31, 2023 /PRNewswire/ -- Lucid
Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or
the "Company") a commercial-stage, cancer prevention medical
diagnostics company and majority-owned subsidiary of PAVmed Inc.
(Nasdaq: PAVM, PAVMZ), today announced that it will host a business
update conference call and webcast on Tuesday, November 14, 2023, at 8:30 AM EST. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief
Executive Officer, will provide a business update, including an
overview of the Company's operations and continued growth strategy.
In addition, Dennis McGrath,
Lucid's Chief Financial Officer, will discuss the Company's
third-quarter 2023 financial results.
The webcast will be available at the investor relations section
of the Company's website at luciddx.com. Alternatively, to
access the conference call by telephone, U.S.-based callers should
dial 1-833-816-1418 and international listeners should dial
1-412-317-0511. All listeners should provide the operator with the
conference call name "Lucid Diagnostics Business Update" to
join.
Following the conclusion of the conference call, a replay will
be available for 30 days on the investor relations section of the
Company's website at luciddx.com.
About Lucid Diagnostics
Lucid Diagnostics Inc. is a
commercial-stage, cancer prevention medical diagnostics company,
and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on
the millions of patients with gastroesophageal reflux disease
(GERD), also known as chronic heartburn, who are at risk of
developing esophageal precancer and cancer.
Lucid's EsoGuard® Esophageal DNA Test is
performed on samples collected in a brief, noninvasive office
procedure with its EsoCheck® Esophageal Cell
Collection Device. EsoGuard and EsoCheck are the first and only
commercially available tools designed with the goal of preventing
cancer and cancer deaths through widespread, early detection of
esophageal precancer in at-risk patients.
For more information, please visit www.luciddx.com and for more
information about its parent company PAVmed, please visit
www.pavmed.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-a-business-update-conference-call-and-webcast-on-november-14-2023-301972766.html
SOURCE Lucid Diagnostics